Marseille, FRANCE – September 27, 2022. Medical imaging specialist Avicenna.AI today announced a groundbreaking partnership with the MedTech company deepc, offering one of the leading radiology AI platforms (deepcOS), to give healthcare providers access to their stroke suite. This move facilitates a step change in patient management for stroke, enabling rapid treatment decisions by combining a uniquely comprehensive stroke management technology with a platform that seamlessly integrates into radiologist's clinical workflow.
Every Second Counts. Avicenna.AI's stroke suite gives radiologists exactly the tools they need to rapidly and automatically identify, triage, and assess patients, enabling faster decision-making and saving lives.
Avicenna.AI's CINA stroke suite provides a full range of tools powered by deep learning to automatically identify acute abnormalities and support the emergency imaging department. It comprises two FDA-cleared, CE-marked tools for automatic triage, and one CE-marked quantification tool:
- CINA-LVO is a triage tool that instantly flags suspected Large Vessel Occlusion (LVO) on CT angiography. Given that every minute of untreated LVO means two million neurons are lost, early diagnosis is critical.
- Real-time trial tool CINA-ICH highlights suspected acute Intracranial Hemorrhage (ICH) on CT scans, efficiently prioritizing cases, drastically reducing the time to treatment. ICH affects over two million people worldwide with a 40-50% mortality rate within one month, so accurate early detection and treatment are vital.
- CINA-ASPECTS is a quantification tool that automatically measures an ASPECT Score to assess ischemic changes in stroke. CINA-ASPECTS enables faster, more consistent, and more precise interpretations for assessing acute ischemic stroke.
To reach its potential, this technology needs to be available to those who need it. That's where deepc comes in, by creating a cutting-edge AI ecosystem providing radiologists instant access to AI-powered technologies. The platform is changing the way AI is adopted by integrating directly into the clinical workflow. Avicenna.AI's full stroke suite is now available through the platform, meaning more physicians and patients can benefit from its tools than ever before.
John Moulden, Chief Commercial Officer at deepc, commented "Our companies bring a challenger mindset to this amazing partnership, and together we offer truly revolutionary technology to healthcare providers and their radiology departments. Looking forward to working together with Avicenna.AI!"